US20040187867A1 - Medicinal powder delivery system - Google Patents
Medicinal powder delivery system Download PDFInfo
- Publication number
- US20040187867A1 US20040187867A1 US10/401,848 US40184803A US2004187867A1 US 20040187867 A1 US20040187867 A1 US 20040187867A1 US 40184803 A US40184803 A US 40184803A US 2004187867 A1 US2004187867 A1 US 2004187867A1
- Authority
- US
- United States
- Prior art keywords
- exit
- vessel
- propellant
- medicinal powder
- tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/07—General characteristics of the apparatus having air pumping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Nozzles (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
- The present invention relates to a novel and useful medicinal powder delivery system.
- Drugs are often delivered in powder form to the lungs of patients, such as asthmatics, and powder medicaments offer several advantages over liquid drugs suspended in propellants in that powder medicaments are premixed and dosages of the same may be more accurately controlled. Also, powder medicaments are easier to manufacture and distribute since refrigeration is not often required.
- Several problems arise with the use of powder medicaments. For example, it is essential that powders do not reagglomerate before or at the time of delivery. Ideally, the delivery of powder medicaments should be in a “soft cloud” or homogeneous aerosol in which the particles constituting the powder remain separated, reagglomeration of particles into larger entities renders the powder as an incompatible entity to the alveolar tissue in the lungs. In other words, agglomerated powder medicaments act as irritants to the respiratory system. Typically, prior systems have mixed propellants with powder medicaments prior to delivery of the drug resulting in reagglomeration during storage or delivery of the mixture.
- Also, it is important that powder medicaments not be contaminated before application to the lungs of a patient. Prior art systems employing fans and the like expose powder medicaments to potential contaminants during the delivery and storage process.
- In addition, it is imperative that a constant and total dose of powder medicament be delivered to a patient in order to achieve a high percentage of absorption of the powder medicament by the alveolar tissue of the lungs. Again, the prior systems have not accomplished this result since dosage depends on various factors such as propellant pressure, timing, and velocity of propellant/powder streams, the ease of use, patient inhalation ability and the like. Also, many prior art powder drug delivery systems use gun-like mechanisms which create a high degree of stress on a patient, making them unsuitable in many cases.
- A medicinal powder delivery system which is effective in safely and conveniently delivering drugs would constitute a remarkable advance in the medical field.
- In accordance with the present invention a novel and useful medicinal powder delivery system is herein provided.
- The system of the present invention is used in conjunction with minimal quantities of a gaseous propellant of known characteristics. The system includes a nozzle having an entrance and exit for passing medicinal powder material through the same. The nozzle may be mounted or supported in a housing in a compact manner.
- A conduit is also employed in the present invention and includes an entrance and exit for passage of a conventional gaseous propellant. The exit of the conduit lies adjacent the nozzle exit within the housing. In addition, the propellant is directed through means for shaping the flow of the characteristics of the gaseous propellant emanating from the gaseous propellant source and exiting the conduit. In this regard a stable vortex field is produced which creates a relatively high vacuum. Such means may take the form of a tube which includes an inner bore and an outer surface. The outer surface of the tube communicates with the conduit and may be formed with a plurality of recesses which interact with the propellant emanating from the gaseous propellant source and traveling through the gaseous propellant conduit. Each recess may be formed into one having a triangular cross-sectional configuration. The bore of the tube may further possess a first portion communicating with the nozzle exit and a second portion serving as an outflow for the powder medicament. In other words, the tube bore permits passage of the medicinal powder from the nozzle exit and outwardly from the tube bore. Most importantly, the outer surface of the tube possessing such means for shaping the flow characteristics of the propellant lies immediately adjacent the outflow of the tube.
- A vessel having a chamber receives the outflow of powder medicament from the tube bore and the propellant flowing from the means for shaping the flow characteristics of the same. The gaseous propellant and the powder medicament are mixed in the chamber and expanded in the vessel. In this regard, the vessel may include an adjacent larger chamber having one or more vent openings to further mix the powder medicament and the gaseous propellant with air in the form of a homogeneous aerosol. The vessel includes an exit permitting egress of the medicinal powder, air, and relatively small amounts of propellant for delivery to a patient. The exit may include a plastic or elastomeric member having an opening of oval cross-sectional configuration to further control the movement of the aerosol.
- Another aspect of the present invention concerns the storage and metering of the medicinal powder. In this regard, a support having a channel and an aperture may be formed on the housing to allow the aperture of the support to communicate with the entrance to the nozzle. The channel is intended to slidable engage items motivated therethrough.
- A cartridge is also employed in the present invention and is sized to slidingly engage or be guided along the channel of the support. The cartridge includes a container having cavity for retaining a predetermined dose of the medicinal powder. Movement of the cartridge along the channel permits the cavity of the cartridge to align with the aperture of the support for the channel. Moreover, a cover may be placed on the cartridge to cover the cavity containing the powder drug to maintain sterility and to prevent contamination of the medicament. The support may further comprise means for removing the cover to permit the cavity to communicate directly with the aperture of the support channel. Such means may take the form of an edge on the channel which engages the cover and peels off the same continuously as the cartridge is advanced along the channel until alignment of the cavity and the aperture of the channel occur. At this juncture, the mere injection of gaseous propellant into the system of the present invention will educe or draw powder medicament from the cavity of the cartridge, mix the powder medicament with the propellant and air for delivery of a measured dose to the user in the form of a low velocity, soft, evenly dispersed aerosol.
- It may be apparent that a novel and useful medicinal powder delivery system has been hereinabove described.
- It is therefore an object of the present invention to provide a medicinal powder delivery system which delivers powder drugs in a homogeneous aerosol that is easy to administer to a patient.
- Another object of the present invention is to provide a medicinal powder delivery system which eliminates reagglomeration of powder medications in alveolar tissue.
- Yet another object of the present invention is to provide a medicinal powder delivery system which is capable of delivering drugs in powder form absent contamination.
- A further object of the present invention is to provide a medicinal powder delivery system which accurately meters the powder drug to produce an accurate and reproducible dose level of the same to the user.
- A further object of the present invention is to provide a medicinal powder delivery system in which a conventional gaseous propellant is employed to maintain dispersion of the powder medication prior to use by a patient.
- Another object of the present invention is to provide a medicinal powder delivery system which is easily controlled by the injection of gaseous propellant into the system.
- Another object of the present invention is to provide a medicinal powder delivery system in which powder drugs are motivated at a controlled flow rate and are electrostatically charged to maintain the dispersion of such particles in an aerosol created thereby.
- Another object of the present invention is to provide a medicinal powder delivery system in which premixing of the powder drug and the propellant is eliminated.
- Another object of the present invention is to provide a medicinal powder delivery system in which the powder drug is loaded into a cartridge and sealed against contamination until activation of the system of the present invention.
- Another object of the present invention is to provide a medicinal powder delivery system in which the powder drug ingestion is easily synchronized with the breathing of the patient.
- Another object of the present invention is to provide a medicinal powder delivery system which does not require the employment of electric motors or pumps to operate.
- Another object of the present invention is to provide a medicinal powder delivery system which is formed into a compact configuration.
- Another object of the present invention is to provide a medicinal powder delivery system which is capable of self-cleaning.
- Another object of the present invention is to provide a medicinal powder delivery system which operates in an efficient manner and does not waste powdered medicine.
- Another object of the present invention is to provide a medicinal powder delivery system which employs a stable vortex eddy field to create a homogeneous aerosol using a powder drug as the solid component.
- Another object of the present invention is to provide a medicinal powder delivery system which does not require special training of the user patient to employ the same.
- Another object of the invention is to provide a medicinal powder delivery system which facilitates dose counting.
- The invention possesses other objects and advantages especially as concerns particular characteristics and features thereof which will become apparent as the specification continues.
- FIG. 1 is a front elevational view of the device of the present invention.
- FIG. 2 is a top plan view of the device of the present invention with the mouthpiece rotated 90 degrees.
- FIG. 3 is a sectional view taken along line3-3 of FIG. 1.
- FIG. 4 is a side elevational view of the nozzle containing portion of the device of the present invention.
- FIG. 5 is an enlarged left side view of the nozzle containing portion depicted in FIG. 4.
- FIG. 6 is a sectional view of an enlargement of the powder and propellant mixing portion of the device of the present invention depicted in FIG. 3 and rotated 90 degrees.
- FIG. 7 is a sectional view of a single cartridge containing powder medicament employed in the device of the present invention.
- FIG. 8 is a top plan view of a trio of cartridges employed with the device of the present invention.
- For a better understanding of the invention reference is made to the following detailed description of the preferred embodiments thereof which should be referenced to the prior described drawings.
- Various aspects of the present invention will evolve from the following detailed description of the preferred embodiments thereof which should be referenced to the prior delineated drawings.
- The preferred embodiment of the present invention is shown in the drawings in its entirety by
reference character 10. Medicinalpowder delivery system 10 includes as one of its elements ahousing 12, FIG. 1.Housing 12 possesses amouth piece 14 having anend portion 16 with anoval opening 18.Oval opening 18 is intended to pass the homogenized aerosol produced bysystem 10 and to contact the mouth of the user for inhalation of such aerosol. In addition,oval opening 18 tends to moderate the velocity of theaerosol leaving system 10 to a certain degree.Slit 20 serves as an entrance to the interior ofhousing 12 and is intended to be one of a plurality of slits which allows air to enterhousing 12, the purpose of which will be discussed hereinafter. In addition, fitting 22 includes anipple 24 and a rotatable sealing cap 26 which is compatible with a standard gaseous propellant source, such is one compatible with powder medicaments, i.e. compressed air and the like. In addition,cartridge 28 includes a spheroidal container for powder medicament which is slidably held by dovetail configuredtracks mouthpiece 14 is capable of rotating according todirectional arrow 33, FIG. 2. Needless to say,mouth piece 14 has be rotated 90 degrees between the renditions shown in FIGS. 1 and 2.Directional arrow 35, FIGS. 1 and 2 indicates the flow of gaseous propellant frompropellant source 36, depicted schematically in FIG. 1. - Referring now to FIG. 3 it may be seen that
housing 12 includes avessel 38 and abase portion 40 connected thereto.Base portion 40 provides a support location for guidingtracks cartridge 28 in place. Also found withinbase portion 40 is anozzle 42 which is intended to transport and accelerate thepowder medicament 44 found withincontainer 30 ofcartridge 28. In this regard,nozzle 32 includes anentrance 46 of relatively wide configuration and anexit 48 of relatively narrow configuration.Directional arrow 50 indicates the motion ofpowder medicament 44 throughnozzle 42.Flange 52 ofnozzle 42 rests onshoulder 54 ofbase member 40 to form apassageway 56 for the gaseous propellant, best shown in FIG. 6. -
Nipple 24, FIG. 1, of fitting 22 takes the form of a hollow member which conducts gaseous propellant toconduit 58 which communicates withpassageway 56. Thus,conduit 58 includes anentrance 60 and anexit 62 for passing gaseous propellant fromsource 36 topassageway 56, which liesadjacent nozzle exit 48. -
Means 60 is also found in the present invention for shaping the flow characteristics of the gaseous propellant emanating fromsource 36 and traveling throughconduit 58 andpassageway 56. Such means may take the form of acylindrical body 62 having abore 64 which communicates with theexit 48 ofnozzle 42. In addition, means 60 includes an outer surface with a plurality ofgrooves 66 which are constructed, in the preferred embodiment depicted in FIGS. 5-6, in a triangular cross-sectional configuration. Gaseous propellant emanating fromsource 36 and traveling throughconduit 58 andpassageway 56 is formed into a vortex field which passes intochamber 68 formed byboss 70 ofbase portion 40,directional arrows 72 and 74. Such movement of gaseous propellant intochamber 68 and the creation of the vortex field creates a sufficient vacuum (as much as 5 psi) by ejection to draw powder medicament fromcontainer 30, throughnozzle 42 and into mixingchamber 68,directional arrow 76. Homogeneously mixed and electrostatically charged cloud ofpowder medicament 77 passes intointerior 78 ofvessel 38, to the interior 80, ofmouth piece 14 and outwardly throughoval opening 18 thereof for use. Thepowder medicament 48 stored incontainer 30 includes particles of a size ranging between 1 and 3 microns.Slits vessel 38 permit air to mix thoroughly with the ejected propellant andmedicinal powder 44 prior to exitingoval opening 18 ofmouthpiece 16. - Referring now to FIGS. 7 and 8 it may be observed that
cartridge 28 is depicted in greater detail.Cartridge 28 includes amain body 86 having a flaredportion 88 which is intended to be gripped by the user.Opening 98 aids in this endeavor.Container 30 includes acavity 92 which is enclosed by acover 94 adhesively held to surface 96 ofcartridge 28.Flap 98 ofcover 94 is peeled away byedge 100 ofbase portion 40 whencartridge 28 is slidingly guided alongchannel members Cavity 92 ofcontainer 30 includes anaperture 102 which communicates withentrance 46 tonozzle 42 whencartridge 28 is in place as depicted in FIG. 3.Directional arrow 104 illustrates the sliding movement ofcartridge 38 betweenchannel members cartridge 28 and exemplified bycartridges frangible portions cartridges housing 12. - In operation, the user grasps
cartridge 28 and slidingly engageschannel members housing 12.Cartridge 28 is then pushed into the position shown in FIG. 3 to allowaperture 102 ofcontainer cavity 94 to communicate withentrance 46 ofnozzle 42.Cover 94, which maintain the integrity and antiseptic condition of an aliquot amount ofpowder medicament 94, is peeled away by engagement ofcover 94 withedge 100 ofbase member 40. To deliver asoft cloud 114 of powder medicament of the user throughoval opening 18, gaseous propellant is directed throughnipple 24,conduit 58,passageway 56, and into contact withmeans 60. The flow of the gas propellant is then shaped into a vortex eddy field which creates a very strong vacuum to educepowder medicament 44 throughnozzle 42 and intochamber 68 where thorough mixing and charging occurs. The aerosol is then mixed with air in theinterior 78 ofvessel 38,directional arrows 116, FIG. 3 and into mouth piece interior 80,directional arrows 118. At this point, the user breathes thehomogeneous aerosol cloud 114 of an accurate does of powder medicament, air and propellant to treat medical conditions such as asthma and the like.Interior 78 is also rendered free of powder medicament through this procedure. - While in the foregoing, embodiments of the present invention have been set forth in considerable detail for the purposes of making a complete disclosure of the invention, it may be apparent to those of skill in the art that numerous changes may be made in such detail without departing from the spirit and principles of the invention.
Claims (18)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/401,848 US6799571B1 (en) | 2002-06-19 | 2003-03-31 | Medicinal powder delivery system |
US10/640,058 US20040187866A1 (en) | 2003-03-31 | 2003-08-14 | Liquid medicament delivery system |
CA 2462353 CA2462353A1 (en) | 2003-03-28 | 2004-03-24 | Liquid medicament delivery system |
CA002462488A CA2462488A1 (en) | 2003-03-31 | 2004-03-30 | Medicinal powder delivery system |
EP04007741A EP1464355A3 (en) | 2003-03-31 | 2004-03-31 | Medicinal powder delivery system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38978702P | 2002-06-19 | 2002-06-19 | |
US10/401,848 US6799571B1 (en) | 2002-06-19 | 2003-03-31 | Medicinal powder delivery system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/640,058 Continuation-In-Part US20040187866A1 (en) | 2003-03-28 | 2003-08-14 | Liquid medicament delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
US20040187867A1 true US20040187867A1 (en) | 2004-09-30 |
US6799571B1 US6799571B1 (en) | 2004-10-05 |
Family
ID=33100937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/401,848 Expired - Fee Related US6799571B1 (en) | 2002-06-19 | 2003-03-31 | Medicinal powder delivery system |
Country Status (1)
Country | Link |
---|---|
US (1) | US6799571B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050263151A1 (en) * | 2004-03-05 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Powder inhaler having a nozzle with a plurality of channels |
US20080190424A1 (en) * | 2005-10-12 | 2008-08-14 | Lucking Samuel W | Unit dose dry powder inhaler |
WO2015006838A1 (en) * | 2013-07-16 | 2015-01-22 | Victor Esteve | Powder inhaler |
CN105413029A (en) * | 2016-01-09 | 2016-03-23 | 陈晓阳 | Quantitative dry-powder medicine suction device |
EP1934805A4 (en) * | 2005-08-25 | 2017-01-11 | Oriel Therapeutics, Inc. | Drug containment systems with sticks, related kits, dry powder inhalers and methods |
CN109843362A (en) * | 2016-10-11 | 2019-06-04 | 凯尔生物治疗药物有限公司 | For generating and being concentrated the device and method of fine grained aerosol |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10244795A1 (en) * | 2002-09-26 | 2004-04-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | powder inhaler |
KR20050091007A (en) * | 2002-12-19 | 2005-09-14 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | Discrete-amount fluid-dispensing system for a personal care device |
US20040187866A1 (en) * | 2003-03-31 | 2004-09-30 | Nathaniel Hughes | Liquid medicament delivery system |
CA2559520A1 (en) * | 2004-03-17 | 2005-09-29 | Genzyme Corporation | Anti-adhesion spraying |
US10441761B2 (en) | 2016-07-01 | 2019-10-15 | Boston Scientific Scimed, Inc. | Delivery devices and methods |
EP3568179B1 (en) | 2017-01-10 | 2021-10-27 | Boston Scientific Scimed, Inc. | Apparatuses for delivering powdered agents |
CN111587129A (en) | 2018-01-12 | 2020-08-25 | 波士顿科学国际有限公司 | Powder for achieving hemostasis |
US11766546B2 (en) | 2018-01-31 | 2023-09-26 | Boston Scientific Scimed, Inc. | Apparatuses and methods for delivering powdered agents |
AU2019355852A1 (en) | 2018-10-02 | 2021-04-01 | Boston Scientific Scimed, Inc. | Devices for fluidization and delivering a powdered agent |
EP4176912A3 (en) | 2018-10-02 | 2023-08-02 | Boston Scientific Scimed, Inc. | Devices for fluidization and delivering a powdered agent |
EP4017377A1 (en) | 2019-12-03 | 2022-06-29 | Boston Scientific Scimed, Inc. | Agent administering medical device |
AU2020396932A1 (en) | 2019-12-03 | 2022-04-14 | Boston Scientific Scimed, Inc. | Medical devices for agent delivery and related methods of use |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5740794A (en) * | 1994-09-21 | 1998-04-21 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US6089228A (en) * | 1994-09-21 | 2000-07-18 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US6158676A (en) * | 1996-06-21 | 2000-12-12 | Hughes Technology Group, L.L.C. | Micro-atomizing device |
US6257233B1 (en) * | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US20010029948A1 (en) * | 1999-12-17 | 2001-10-18 | Ingle Frank W. | Systems and methods for extracting powders from receptacles |
-
2003
- 2003-03-31 US US10/401,848 patent/US6799571B1/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5740794A (en) * | 1994-09-21 | 1998-04-21 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US6089228A (en) * | 1994-09-21 | 2000-07-18 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US6158676A (en) * | 1996-06-21 | 2000-12-12 | Hughes Technology Group, L.L.C. | Micro-atomizing device |
US6257233B1 (en) * | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US20010029948A1 (en) * | 1999-12-17 | 2001-10-18 | Ingle Frank W. | Systems and methods for extracting powders from receptacles |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050263151A1 (en) * | 2004-03-05 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Powder inhaler having a nozzle with a plurality of channels |
US7984713B2 (en) * | 2004-03-05 | 2011-07-26 | Boehringer Ingelheim International Gmbh | Powder inhaler having a nozzle with a plurality of channels |
EP1934805A4 (en) * | 2005-08-25 | 2017-01-11 | Oriel Therapeutics, Inc. | Drug containment systems with sticks, related kits, dry powder inhalers and methods |
US20080190424A1 (en) * | 2005-10-12 | 2008-08-14 | Lucking Samuel W | Unit dose dry powder inhaler |
WO2015006838A1 (en) * | 2013-07-16 | 2015-01-22 | Victor Esteve | Powder inhaler |
CN105413029A (en) * | 2016-01-09 | 2016-03-23 | 陈晓阳 | Quantitative dry-powder medicine suction device |
CN109843362A (en) * | 2016-10-11 | 2019-06-04 | 凯尔生物治疗药物有限公司 | For generating and being concentrated the device and method of fine grained aerosol |
Also Published As
Publication number | Publication date |
---|---|
US6799571B1 (en) | 2004-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6799571B1 (en) | Medicinal powder delivery system | |
EP0711572B1 (en) | Inhalation medicator | |
US20190247607A1 (en) | Inhalator | |
EP1923087B1 (en) | Unit dose capsules for dry powder inhaler | |
JP4395642B2 (en) | Simple inhaler | |
US5429122A (en) | Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber | |
US8201555B2 (en) | Inhaler | |
KR100323942B1 (en) | Medicine Inhaler and Inhalation Method | |
AU7432491A (en) | Device for the administration of powdered medicinal substances | |
US20120174923A1 (en) | Unit Dose Capsules and Dry Powder Inhaler | |
JPH09253208A (en) | Medicator for nasal cavity | |
NZ540936A (en) | Inhalation device for transpulmonary administration | |
JPS6190674A (en) | Drug administration apparatus | |
US6742721B2 (en) | Shock wave aerosolization method and apparatus | |
EP1464355A2 (en) | Medicinal powder delivery system | |
EP1506792A2 (en) | Liquid medicament delivery system | |
JP3547584B2 (en) | Dosing device | |
JPH11299892A (en) | Inhalation type medicine administration device | |
JPH09140792A (en) | Medicator | |
CA2462353A1 (en) | Liquid medicament delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MOLECULAR ROTATION, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUGHES, NATHANIEL;SHAW, LEON;REEL/FRAME:013926/0775 Effective date: 20030326 |
|
AS | Assignment |
Owner name: MOLECULAR ROTATION, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOLECULAR ROTATION, LLC;REEL/FRAME:015567/0548 Effective date: 20040525 |
|
AS | Assignment |
Owner name: HUGHES, NATHANIEL, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOLECULAR ROTATION, INC.;REEL/FRAME:017400/0431 Effective date: 20051007 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
AS | Assignment |
Owner name: FLUID ENERGY CONVERSION, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HUGHES, NATHANIEL;REEL/FRAME:023348/0263 Effective date: 20091005 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 8 |
|
SULP | Surcharge for late payment |
Year of fee payment: 7 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Expired due to failure to pay maintenance fee |
Effective date: 20161005 |